documents: FDA-2015-D-1211-0022
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2015-D-1211-0022 | FDA | FDA-2015-D-1211 | Ref. 19 FDA Blood Products Advisory Committee Meeting, September 14, 2000 re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry | Supporting & Related Material | Background Material | 2015-05-18T04:00:00Z | 2015 | 5 | 2015-05-18T18:45:12Z | 0 | 0 | 0900006481ae6a9e |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref